Vicore signs deal with Alex to develop digital therapeutic to support IPF patientsRare disease specialist Vicore Pharma has signed an agreement with Alex Therapeutics to test a digital therapeutic designed Share XVicore signs deal with Alex to develop digital therapeutic to support IPF patientshttps://pharmaphorum.com/news/vicore-signs-deal-with-alex-to-develop-digital-therapeutic-to-support-ipf-patients/
Vicore builds case for C21 drug in hospitalised COVID-19 patientsTwo weeks ago, Vicore reported mid-stage data showing that its lead drug C21 could boost the benefit of Share XVicore builds case for C21 drug in hospitalised COVID-19 patientshttps://pharmaphorum.com/news/vicore-builds-case-for-c21-drug-in-hospitalised-covid-19-patients/
